TY - JOUR
T1 - The role of bariatric surgery in the treatment of type 2 diabetes
T2 - current evidence and clinical guidelines.
AU - Via, Michael A.
AU - Mechanick, Jeffrey I.
PY - 2013/11
Y1 - 2013/11
N2 - The incidence of type 2 diabetes (T2D) continues to rise worldwide. The management of T2D is challenging and therefore amenable to multimodality treatment options. Many published observations of obese individuals with T2D that have undergone bariatric surgery consistently demonstrate remarkable improvement and short-term remission of T2D. Recently published randomized trials confirm these findings and demonstrate significantly improved glycemic control following bariatric procedures, especially Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. However, the question of long-term remission remains uncertain. Clinicians may consider the use of bariatric surgery as a treatment option for certain obese patients with T2D who have failed intensive lifestyle intervention and conventional pharmacotherapy.
AB - The incidence of type 2 diabetes (T2D) continues to rise worldwide. The management of T2D is challenging and therefore amenable to multimodality treatment options. Many published observations of obese individuals with T2D that have undergone bariatric surgery consistently demonstrate remarkable improvement and short-term remission of T2D. Recently published randomized trials confirm these findings and demonstrate significantly improved glycemic control following bariatric procedures, especially Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. However, the question of long-term remission remains uncertain. Clinicians may consider the use of bariatric surgery as a treatment option for certain obese patients with T2D who have failed intensive lifestyle intervention and conventional pharmacotherapy.
UR - http://www.scopus.com/inward/record.url?scp=84899041109&partnerID=8YFLogxK
U2 - 10.1007/s11883-013-0366-0
DO - 10.1007/s11883-013-0366-0
M3 - Review article
C2 - 24078316
AN - SCOPUS:84899041109
SN - 1523-3804
VL - 15
SP - 366
JO - Current Atherosclerosis Reports
JF - Current Atherosclerosis Reports
IS - 11
ER -